A 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3, 6-trideoxy-?-L-lyxo-hexopyranosyl)oxy]-7,8 ,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)- DMF (Drug Master File) is a document detailing the whole manufacturing process of 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3, 6-trideoxy-?-L-lyxo-hexopyranosyl)oxy]-7,8 ,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)- active pharmaceutical ingredient (API) in detail. Different forms of 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3, 6-trideoxy-?-L-lyxo-hexopyranosyl)oxy]-7,8 ,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)- DMFs exist exist since differing nations have different regulations, such as 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3, 6-trideoxy-?-L-lyxo-hexopyranosyl)oxy]-7,8 ,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)- USDMF, ASMF (EDMF), JDMF, CDMF, etc.
										A 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3, 6-trideoxy-?-L-lyxo-hexopyranosyl)oxy]-7,8 ,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)- DMF submitted to regulatory agencies in the US is known as a USDMF. 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3, 6-trideoxy-?-L-lyxo-hexopyranosyl)oxy]-7,8 ,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)- USDMF includes data on 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3, 6-trideoxy-?-L-lyxo-hexopyranosyl)oxy]-7,8 ,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3, 6-trideoxy-?-L-lyxo-hexopyranosyl)oxy]-7,8 ,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)- USDMF is kept confidential to protect the manufacturer’s intellectual property.
										click here to find a list of 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3, 6-trideoxy-?-L-lyxo-hexopyranosyl)oxy]-7,8 ,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)- suppliers with USDMF on PharmaCompass.